New FDA-Approved Drug Doubles Survival Rates
Share on PinterestThe FDA approved Rasonque (daraxonrasib), a groundbreaking new drug to treat metastatic pancreatic cancer. Photo courtesy of Revolution Medicines The FDA approved Rasonque, a new drug to treat the most common type of pancreatic cancer. A clinical trial found that those who received Rasonque had more than double the average survival rate: around […]
